Neurodegenerative Disorders Flashcards

1
Q

When neurons die can they be replaced?

A

No when neurons die they cannot be replaced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Name two neurodegenerative disease that causes death of neurons

A

-Alzheimer’s disease
-Parkinson’s disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Which neurodegenerative diseases are responsible for protein folding

A

-Alzheimer’s disease
-Parkinson’s disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which protein is folded in Parkinson’s disease

A

a(Alpha )synuclein (mutations)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Which protein is misfolded in Alzheimer’s disease

A

-Beta-amyloid protiens(AB)
-Tau proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe mechanism of protein misfolding and how it causes pathology

A

-first genetic mutation leads to misfolding of proteins which can form and insoluble aggregate which gets deposited intracellular and extra cellular
-leading to neurotoxicity which is demonstrated by excitotoxicity ,oxidative stress and apoptosis and necrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the chief symptoms of Parkinson’s disease

A

-Bradykinesia
-muscle rigidity and when movement starts it cannot stop as well as initiate
-Tremor at rest
-cognitive impairment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the pathogenesis of Parkinson’s disease

A

Gradual loss of dopamine when the striatal dopamine content has fallen 20-40 % of normal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Parkinson’s disease is associated with what conditions

A

-dementia
-depression
-autonomic dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the mechanisms of action of Parkinson’s drug treatment

A

-you reduce the release of acetylcholine in striatum by increasing dopaminergic effects
-you block the NMDA receptors to inhibit release of acetylcholine
-Lastly you reduce acetylcholine by Muscarinic receptor antagonism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

So in essence the drugs for Parkinson’s is classified into

A

*Dopaminomimetics
-NDMA receptor antagonist
-central Muscarinic cholinergic antagonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

List drugs for treatment of Parkinson’s disease

A

-levodopa with combination of carbidopa and as well as entacapone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Parkinson’s drugs mention 2 drugs that are dopamine agonists

A

-Bromocriptine
-Ropinirole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Pkd drugs- mention 2 Monamine oxidase B(MAO-B) inhibitors

A

-Selegiline
-resagiline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Cathechol-o-methyl transferase inhibitors

A

Entacapone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

NMDA receptor blockers is ?

A

Amantadine

17
Q

Muscarinic Acetylcholine receptor antagonists

A

Orphenadrine
Procyclidine

18
Q

Pharmacokinetics of levodopa

A

*95% of levodopa is converted into dopamine in the intestine and can cause side effects only 5% gets into the brain

19
Q

Side effects of levodopa

A

-Dyskinesia (involuntary movement)
-Hypotension
-schizophrenic like syndrome like hallucinations,night mares ,insomnia
-nausea and anorexia

20
Q

Short notes on bromocriptide and why it was stopped

A

Bromocriptine, and cabergoline are dopamine agonists that are stopped due to side effects of fibrotic reactions in lungs , retroperitoneum and pericardium

21
Q

Side effects of dopamine angonists ropinirole include

A

-over eating
-gambling and excessive sexual behavior
-hallucinations and somnolence

22
Q

Good sides of dopamine agonists

A

-can improve mood
-have neurological protective activity
-D2/3 selective and better tolerated and do not show the fluctuations in efficacy

23
Q

Unwanted side effects of muscarinic antagonists

A

-dry mouth
-constipation
-urinary retention
-Mydiarisis
-Tachycardia

24
Q

Treatment of Parkinson’s disease and management which drug is contraindicated and what age?

A

-Patients age 65 we should not give muscarinic antagonist

25
Patient with age 50-70 with moderate motor disorders which drugs can we start with
Agonist of dopamine plus inhibitor of MOA)B amantadine, or muscarinic antagonists for patients less than 65
26
Age of patient 50-70 years with expressed motor and Cognitive Impairment which drugs should we administer
-start with levodopa -if not improved add agonists of dopamine or inhibitor of MAO B or amantadine
27
Describe pathogenesis Alzheimer’s disease
Brain shrinkage and loss of focal cholinergic neurons in basal forebrain and hippocampus
28
Give 2 microscopic features of Alzheimer’s disease
-Amyloid plaques extra cellular deposits of Beta amyloid -Intraneuronal neurofibrillary tangles (tau protein)
29
Give 3 drugs for treatment of Alzheimer’s disease
1-choline alfascerate(precursor of acetylcholine)400 mg 2-Cholinesterase inhibitors: Rivastigmine Donepezil Galantamine 3 antiexitotoxic agent: Memantine